Injectable HIV treatment underway in England and largely effective, but a couple of breakthrough cases raise concern
TAF may be effective as once-weekly PrEP
Adequate levels of folate protect against neural tube defects when taking dolutegravir
Folic acid supplements should be standard for pregnant women with HIV where there is a risk that dietary folate intake is low
Criminalisation of homosexuality undermines HIV testing in sub-Saharan Africa
CRISPR gene therapy EBT-101 does not prevent HIV viral rebound
Persistent low-level viraemia raises the risk of serious non-AIDS events
“If anyone asks, I just keep silent”: the impact of stigma on Vietnamese women living with HIV
Blood-borne virus testing in emergency departments will more than double in England, first Scottish sites planned
Biggest single reason for people with HIV dropping out of care is stigma, doctors report
“You don’t fit into any of the boxes”: trans men’s experiences with PrEP
Limited access to anal cancer screening among people with HIV in the US
Lack of awareness and provider capacity mean less than 1 in 20 at highest risk were screened in 2019
Adrenal insufficiency common in people with HIV, often unrecognised
De-simplifying treatment is acceptable and cost-saving, if a choice is offered
Mandatory de-simplification was unpopular and failed to save money